Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
Introduction and purpose: Elevated FGF23 in X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) leads to systemic hypophosphatemia, several musculoskeletal manifestations and rickets in children. In this review we describe advances in the management of XLH and TIO using burosumab...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2023-07-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/44798 |